Semax
← All compounds

Semax

Well Researched

First effectsDays 1-3
Full benefitsWeek 4
Category 2

Semax is a synthetic peptide originally derived from a stress-response hormone (ACTH), extensively studied for its cognitive, brain-protective, and neuro-repair properties. Originally developed in Russia for stroke recovery, this brain-targeted peptide rapidly increases BDNF levels and works on dopamine and serotonin systems to enhance cognitive function, memory, and focus.

How it works

Semax works primarily by boosting BDNF (brain-derived neurotrophic factor), a protein that supports the growth and survival of brain cells. Higher BDNF levels improve the brain's ability to form new connections, which translates to better memory, faster learning, and sharper focus. Semax also increases dopamine and serotonin activity, supporting motivation, mood, and mental stamina. In damaged brain tissue, it promotes repair by stimulating nerve growth factors and reducing inflammation.

Key benefits

  • Rapidly boosts BDNF, a key protein for learning and memory
  • Backed by extensive clinical research
  • Easy to self-administer via nasal spray
  • Reaches the brain quickly and efficiently via nasal spray

Related goals

Protocols

ProtocolDoseFrequency
Standard focus (nasal spray)300-600mcg1-2x daily
Learning and memory support600-900mcg2-3x daily during study periods
Anti-fatigue cognitive support400-800mcgSingle morning dose
Research cognitive (injection)500-750mcgOnce daily

Protocols are from published research literature. This is not medical advice. Dosing should be determined by a licensed clinician.

What to expect

Days 1-3

Initial cognitive clarity and focus enhancement.

Week 1

Improved attention span and mental stamina.

Week 2-3

Enhanced memory consolidation and learning capacity.

Week 4

Peak cognitive benefits with improved stress resilience.

What to know

  • Start with lowest effective dose (300mcg)
  • Avoid concurrent use with other nasal medications that cause vasoconstriction
  • Monitor for nasal irritation, bleeding, or persistent discomfort
  • Do not exceed 4-week continuous use without medical supervision
  • Potential to enhance effects of stimulants. Reduce other stimulant doses if combining.
  • Limited human safety data for injection route

Key research

Gusev EI et al. · Zhurnal Nevrologii i Psikhiatrii · 2018
Lebedeva IS et al. · Bulletin of Experimental Biology and Medicine · 2018
Dolotov OV et al. · Journal of Neurochemistry · 2006